ZA979071B - Detecting genetic predisposition to sight-threatening diabetic retinopathy - Google Patents
Detecting genetic predisposition to sight-threatening diabetic retinopathyInfo
- Publication number
- ZA979071B ZA979071B ZA979071A ZA979071A ZA979071B ZA 979071 B ZA979071 B ZA 979071B ZA 979071 A ZA979071 A ZA 979071A ZA 979071 A ZA979071 A ZA 979071A ZA 979071 B ZA979071 B ZA 979071B
- Authority
- ZA
- South Africa
- Prior art keywords
- sight
- diabetic retinopathy
- genetic predisposition
- identified
- threatening
- Prior art date
Links
- 206010012689 Diabetic retinopathy Diseases 0.000 title abstract 3
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 title 1
- 206010071602 Genetic polymorphism Diseases 0.000 abstract 2
- 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 abstract 1
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 abstract 1
- 102100039065 Interleukin-1 beta Human genes 0.000 abstract 1
- 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 abstract 1
- 101710144554 Interleukin-1 receptor antagonist protein Proteins 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 102000054765 polymorphisms of proteins Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Catching Or Destruction (AREA)
- Eye Examination Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9621129.7A GB9621129D0 (en) | 1996-10-10 | 1996-10-10 | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA979071B true ZA979071B (en) | 1998-07-08 |
Family
ID=10801212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA979071A ZA979071B (en) | 1996-10-10 | 1997-10-09 | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6713253B1 (fr) |
| EP (1) | EP0950113B1 (fr) |
| AT (1) | ATE224456T1 (fr) |
| AU (1) | AU742957B2 (fr) |
| CA (1) | CA2267155C (fr) |
| DE (1) | DE69715669T2 (fr) |
| DK (1) | DK0950113T3 (fr) |
| ES (1) | ES2186926T3 (fr) |
| GB (1) | GB9621129D0 (fr) |
| IL (1) | IL129390A (fr) |
| WO (1) | WO1998015653A1 (fr) |
| ZA (1) | ZA979071B (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6524795B1 (en) | 1997-03-10 | 2003-02-25 | Interleukin Genetics, Inc. | Diagnostics for cardiovascular disorders |
| US6720141B1 (en) * | 1999-11-01 | 2004-04-13 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for restenosis |
| GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| US20050032077A1 (en) * | 1998-03-10 | 2005-02-10 | Duff Gordon W. | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
| EP1071822A2 (fr) * | 1998-04-21 | 2001-01-31 | Interleukin Genetics, Inc. | Epreuve foetale de prevision de poids faible a la naissance |
| US6733967B1 (en) | 1998-04-21 | 2004-05-11 | Interleukin Genetics, Inc. | Fetal testing for prediction of low birth weight |
| US6251598B1 (en) | 1998-10-30 | 2001-06-26 | Interleukin Genetics, Inc. | Methods for diagnosing sepsis |
| US20090023147A1 (en) * | 1999-08-30 | 2009-01-22 | Kenneth Kornman | Diagnostics and therapeutics for osteoporosis |
| CA2398900A1 (fr) * | 2000-01-31 | 2001-08-09 | Santen Pharmaceutical Co., Ltd. | Agents therapeutiques pour troubles ophtalmiques |
| GB0009294D0 (en) * | 2000-04-15 | 2000-05-31 | Sec Dep For The Home Departmen | Improvements in and relating to analysis of DNA samples |
| JP4492849B2 (ja) * | 2001-11-19 | 2010-06-30 | インターリューキン ジェネティックス インコーポレイテッド | 転写および炎症性疾患および感染症に対する感受性に影響するインターロイキン−１遺伝子座の機能的多型 |
| TWI346700B (en) | 2002-01-25 | 2011-08-11 | Interleukin Genetics Inc | The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| EP1554400A1 (fr) * | 2002-10-15 | 2005-07-20 | Novartis AG | Methodes pour prevoir des phenomenes d'oedeme comme effets secondaires de traitement medicamenteux |
| JP2007501627A (ja) * | 2003-08-08 | 2007-02-01 | インタールーキン ジェネティックス インク | 骨粗鬆症のための診断法および治療法 |
| GB0417763D0 (en) * | 2004-07-09 | 2004-09-08 | Sec Dep For The Home Departmen | Improvements in and relating to the investigation of dna samples |
| EP1951903A2 (fr) | 2005-10-25 | 2008-08-06 | Interleukin Genetics, Inc. | Famille de genes il-1 et polymorphismes et haplotypes associes |
| AU2007230570A1 (en) * | 2006-03-24 | 2007-10-04 | University Of Louisville Research Foundation, Inc. | Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders |
| US20090222212A1 (en) * | 2006-04-03 | 2009-09-03 | Forensic Science Services Ltd. | analysis of mixed source dna profiles |
| WO2009015087A2 (fr) * | 2007-07-20 | 2009-01-29 | Potentia Pharmaceuticals, Inc. | Compositions et procédés de traitement d'un traumatisme |
| ES2337115B2 (es) * | 2007-09-26 | 2011-01-24 | Universidade De Santiago De Compostela | Metodo para la deteccion del riesgo de desarrollar vitreorretinopatiaproliferante (vrp). |
| CA2705142A1 (fr) * | 2007-11-08 | 2009-05-14 | Interleukin Genetics, Inc. | Diagnostics pour des troubles dermatologiques lies au vieillissement |
| EP2283156B1 (fr) * | 2008-05-02 | 2015-11-11 | Interleukin Genetics, Inc. | Détection de prédisposition génétique à des pathologies associées à l'arthrose |
| EP2304052A2 (fr) * | 2008-05-02 | 2011-04-06 | Interleukin Genetics, Inc. | Détection d'une prédisposition génétique à des états associés à l'ostéoarthrite |
| US10894985B2 (en) | 2016-01-12 | 2021-01-19 | Sitokine Limited | Methods for predicting response to treatment |
| US10337070B2 (en) | 2017-01-12 | 2019-07-02 | Cardioforecast Ltd. | Methods and kits for treating cardiovascular disease |
| US20220249660A1 (en) | 2019-06-06 | 2022-08-11 | Sitokine Limited | Compositions and methods for treating lung, colorectal and breast cancer |
| WO2021028469A1 (fr) | 2019-08-12 | 2021-02-18 | Sitokine Limited | Compositions et méthodes de traitement du syndrome de libération de cytokines et de neurotoxicité |
| WO2021205013A1 (fr) | 2020-04-09 | 2021-10-14 | Sitokine Limited | Compositions et méthodes de traitement de la covid-19 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1314811C (fr) | 1985-06-14 | 1993-03-23 | Gerald T. Nepom | Methodes permettant de detecter les genes allelomorphes associes a un risque accru de diabete |
| US5039606A (en) | 1987-10-29 | 1991-08-13 | Virginia Mason Research Center | Diagnostic probe for diabetes type I predisposition |
| US5686246A (en) | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| US5698399A (en) | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
-
1996
- 1996-10-10 GB GBGB9621129.7A patent/GB9621129D0/en active Pending
-
1997
- 1997-10-09 DE DE69715669T patent/DE69715669T2/de not_active Expired - Lifetime
- 1997-10-09 IL IL12939097A patent/IL129390A/en not_active IP Right Cessation
- 1997-10-09 AU AU46311/97A patent/AU742957B2/en not_active Ceased
- 1997-10-09 AT AT97944986T patent/ATE224456T1/de not_active IP Right Cessation
- 1997-10-09 ZA ZA979071A patent/ZA979071B/xx unknown
- 1997-10-09 WO PCT/GB1997/002790 patent/WO1998015653A1/fr active IP Right Grant
- 1997-10-09 US US09/037,472 patent/US6713253B1/en not_active Expired - Fee Related
- 1997-10-09 EP EP97944986A patent/EP0950113B1/fr not_active Expired - Lifetime
- 1997-10-09 CA CA002267155A patent/CA2267155C/fr not_active Expired - Fee Related
- 1997-10-09 ES ES97944986T patent/ES2186926T3/es not_active Expired - Lifetime
- 1997-10-09 DK DK97944986T patent/DK0950113T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| AU742957B2 (en) | 2002-01-17 |
| CA2267155C (fr) | 2003-07-08 |
| AU4631197A (en) | 1998-05-05 |
| WO1998015653A1 (fr) | 1998-04-16 |
| IL129390A0 (en) | 2000-02-17 |
| CA2267155A1 (fr) | 1998-04-16 |
| EP0950113A1 (fr) | 1999-10-20 |
| US6713253B1 (en) | 2004-03-30 |
| GB9621129D0 (en) | 1996-11-27 |
| ES2186926T3 (es) | 2003-05-16 |
| DE69715669T2 (de) | 2003-09-18 |
| DE69715669D1 (de) | 2002-10-24 |
| ATE224456T1 (de) | 2002-10-15 |
| EP0950113B1 (fr) | 2002-09-18 |
| IL129390A (en) | 2002-05-23 |
| DK0950113T3 (da) | 2003-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL129390A0 (en) | Method and kit for detecting genetic predisposition to slight-threatening diabetic retinopathy | |
| Dombrowski et al. | Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles | |
| Labuda et al. | Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay | |
| MY132156A (en) | Detecting genetic predisposition to periodontal disease | |
| DE69029018D1 (de) | Verfahren zum Nachweis von benachbarten und entfernt lokalisierten Allelen als Haplotypen mittels Intronsequenzanalyse | |
| IL122808A0 (en) | Kit for detecting genetic predisposition for osteoporosis | |
| WO2002086163A8 (fr) | Procedes d'analyse genomique a haut rendement mettant en oeuvre des microreseaux etiquetes au niveau de sites de restriction | |
| WO2001090419A3 (fr) | Methodes d'analyse genetique d'adn servant a detecter des variances de sequence | |
| WO1998028444A3 (fr) | Micropuces oligonucleotidiques sur mesure utilisees comme capteurs multiples | |
| NZ284412A (en) | Apolipoprotein E polymorphism and treatment of Alzheimer's Disease | |
| EP0398709A3 (fr) | Diagnostic génétique de dystonie de torsion | |
| WO2001026029A3 (fr) | Procede et systeme permettant de fournir sur un reseau informatique des renseignements cliniques sur le genotype | |
| GB9604305D0 (en) | Diagnostic method and apparatus | |
| WO2001004349A3 (fr) | Diagnostic ou pronostic de la maladie d'alzheimer et composition therapeutique pour la prevention ou le traitement de la maladie d'alzheimer | |
| DE69710469D1 (de) | Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus | |
| EP0226288A3 (fr) | Moyens et procédé de dosage de fibrose cystique à base d'une liaison génétique | |
| WO2002053018A3 (fr) | Procede d'identification et de gestion de l'augmentation des risques de cancer du sein associes a des polymorphismes des genes mhc | |
| WO2003106652A3 (fr) | Methode d'analyse genetique basee sur l'haplotype, permettant de determiner le risque de developper une resistance a l'insuline, une maladie coronarienne et d'autres phenotypes | |
| WO2001077380A3 (fr) | Sequences | |
| Giannattasio et al. | Detection of microsatellites by ethidium bromide staining. The analysis of an STR system in the human phenylalanine hydroxylase gene | |
| CA2263712A1 (fr) | Methodes permettant de diagnostiquer et d'evaluer une predisposition aux troubles bipolaires de l'humeur | |
| Käller et al. | Detection of MC1R polymorphisms with protease-mediated allele-specific extension as an alternative to direct sequencing | |
| WO2003023063A1 (fr) | Methode d'estimation du risque d'apparition de diabetes | |
| WO1997032998A3 (fr) | Materiels et procedes relatifs a l'identification d'un polymorphisme associe a une sensibilite a des pathologies | |
| WO1999014374A3 (fr) | Procede de determination de susceptibilite genetique a une nephropathie diabetique |